Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
280.00    0.00 (0.00%)
Bid:
270.00
Ask:
290.00
Spread: 20.00 (7.407%)
Market Cap: £48.76m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

Rule 8.1- Character Group PLC

24 Mar 2006 14:55

Nigel Dobbs24 March 2006 FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) NIGEL DOBBS Company dealt in CHARACTER GROUP Class of relevant security to which the dealings being disclosed relate (Note 2) Date of dealing 23/3/06 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 775,000 (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SALE 20000 71pSALE 10000 70p (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit (Note 5)call option (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) YES/NO Date of disclosure 24/03/2006 Contact name EMMA CHAPMAN Telephone number 02890 323456 Name of offeree/offeror with which associated Specify category and nature of associate status (Note 10) Notes The Notes on Form 8.1 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:13 pmRNSTransaction in Own Shares
14th Feb 20245:38 pmRNSTransaction in Own Shares
13th Feb 20245:49 pmRNSTransaction in Own Shares
9th Feb 20244:19 pmRNSTransaction in Own Shares
8th Feb 20245:44 pmRNSTransaction in Own Shares
7th Feb 202410:20 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSShare Buyback Programme
19th Jan 20244:41 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement - Trading Update
14th Dec 202312:53 pmRNSHolding(s) in Company
14th Dec 202312:49 pmRNSHolding(s) in Company
12th Dec 20237:01 amRNSFinal Results - year ended 31 August 2023
12th Dec 20237:00 amRNSBoard Changes
23rd Oct 20234:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSTrading Update
22nd Sep 20234:08 pmRNSHolding(s) in Company
20th Sep 20235:30 pmRNSHolding(s) in Company
22nd Aug 20237:00 amRNSHolding(s) in Company
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
17th May 202311:32 amRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSHolding(s) in Company
15th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSHalf-year Report - six months to 28 February 2023
27th Mar 20236:00 pmRNSHolding(s) in Company
20th Jan 20234:41 pmRNSResult of AGM
20th Jan 20237:00 amRNSTrading update ahead of the AGM
28th Dec 20227:34 amRNSDirector's share dealings, Treasury shares and TVR
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
22nd Dec 20227:00 amRNSAUDITED ANNUAL RESULTS -YEAR ENDED 31 AUGUST 2022
21st Oct 20221:41 pmRNSTransfer of treasury shares & Total Voting Rights
19th Oct 20221:39 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update
12th Sep 20224:45 pmRNSTransfer of treasury shares & Total Voting Rights
15th Aug 20225:08 pmRNSHolding(s) in Company
15th Aug 20229:33 amRNSHolding(s) in Company
10th Aug 202211:55 amRNSHolding(s) in Company
30th Jun 202210:00 amRNSDirectorate change and New Senior appointment
9th Jun 20221:09 pmRNSTreasury Stock and Total Voting Rights
1st Jun 20227:00 amRNSNon-Executive Director appointment
12th May 20227:00 amRNSHalf-Yearly Report-six months to 28 February 2022
10th May 20225:15 pmRNSHolding(s) in Company
24th Mar 20224:12 pmRNSTotal Voting Rights & Transfer of Treasury Shares
25th Feb 20221:10 pmRNSCorrection to Directors’ Holdings
25th Feb 202212:57 pmRNSTreasury shares transfer,exercise of share options
24th Feb 202211:41 amRNSHolding(s) in Company - Correction
23rd Feb 20224:12 pmRNSHolding(s) in Company
23rd Feb 20224:08 pmRNSHolding(s) in Company
14th Feb 20227:00 amRNSResults of Tender Offer and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.